Facing Life's Challenges PDF Print E-mail
Sunday, 16 January 2011 20:56
At 57 years of age Anne Wersching doesn’t have a single wrinkle on her face.

Sitting in her lounge room in Bayswater North, Ms Wersching looks well, save for a few red marks on her cheeks.

But Ms Wersching has a little-known disease called scleroderma, a progressive disease of the connective tissue that causes a range of symptoms. It is not known what causes scleroderma but it affects about one in 4400 people and tends to occur more often in women than in men.

Ms Wersching was diagnosed in 1998, almost 10 years after her first symptoms.

“I had bad reflux and my fitness was going downhill quite rapidly,” Ms Wersching said. “The doctors (initially) said: ‘You’ve got too much weight on you, you need to lose weight, you’re drinking too much’, things like that.”

But the reflux continued and Ms Wersching developed calcification in her fingertips, sensitivity to cold and poor blood flow.

She also developed the tell-tale sign of scleroderma, a thickening and tightening of the skin, particularly on the face and hands.

This tightening is what has prevented Ms Wersching’s wrinkles.

“I haven’t got wrinkles and I’m 57 - I look like I’ve had a facelift. It’s the one advantage,” Ms Wersching said.

Since her diagnosis other signs and symptoms have included a loss of iron, hypertension, and red marks on her face due to burst blood vessels. Since 2000 Ms Wersching has lost 40 per cent of her lung capacity. “Even just doing simple things like making my bed takes me an hour because I have to stop and rest with my lung condition,” Ms Wersching said.

“I’ve just got to take things a lot slower; I get very frustrated by that.” Ms Wersching moved from a private practice as a tax accountant to her home where she could rest through the day.

Eighteen months ago she tried a new treatment to prevent her condition worsening.

“They put me through a course of chemotherapy but only a small dose,” Ms Wersching said.

“It seems to have worked because the lungs have not got worse over the past 12 months, so we’re hoping.”

But Ms Wersching is not one to let the disease get her down and with the support of her husband Gunter and their three children, Ben, Kara and Emma, tries to keep her spirits up.

“Sometimes the doctors will say: ‘How bad are you really because you seem OK and we know damn well that you’re not’.”

Source: Ainsworth, M. (2010), "Facing life's challenges", Knox Leader; can be viewed here.
 
More articles :

» Frequency of Sexual Dysfunction In Women With Rheumatic Diseases

Sexuality is part of human life and of quality of life, accounting for individual well-being. It relates not only to sexual intercourse itself, but also to a whole spectrum that ranges from self-image and self-valuing to relationship with the...

» TLR4 Protein Implicated In The Fibrosis Associated With Scleroderma

An international multi-disciplinary research team led by scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.Recently reported in the , this finding has implications for...

» Knowing When to Get a Second Doctor’s Opinion

Knowing When to Get a Second Doctor’s Opinion. You won’t often hear doctors say it, but medicine is not an exact science. Not all diseases are clear-cut and easy to diagnose. Not all patients with the same condition will experience the same...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» Long Term Methotrexate Therapy Beneficial for Juvenile Localized Scleroderma

Researchers in Italy evaluated 65 patients with Juvenile Localized (JLS; or) previously enrolled in a double blind, randomized control trial and treated for the first 3 months with oral methotrexate (MTX; 15 mg/m2 weekly) and prednisone (1 mg/kg...

» U.S. Legislation Passed to Promote Research and Awareness of Scleroderma

(U.S.) has applauded the U.S. House of Representatives for the passage of the Scleroderma Research and Awareness Act (H.R. 2408), introduced last March by Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI). This bipartisan legislation gives hope to...